Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Flow cytometry: The core characterisation technique for developing next-generation cancer immunotherapies
By Karen Loudon / August 28, 2019
CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that...
Read More
Monash University Student Open Day
By Karen Loudon / August 27, 2019
A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham...
Read More
Can an immune strategy used to treat cancer also wipe out HIV infections?
By Karen Loudon / August 12, 2019
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre...
Read More
